Basic Information
LncRNA/CircRNA Name | lncRNA-ATB |
Synonyms | LOC109207222 |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | cholangiocarcinoma |
ICD-0-3 | NA |
Methods | qRT-PCR, Western blotting, in vitro knockdown etc. |
Sample | CCA tissues and corresponding non-cancer tissues, human bronchial epithelial cell BEC and four CCA cell lines (HUCCT1, RBE, TFK1 and Huh-28) |
Expression Pattern | up-regulated |
Function Description | CCA tissues have increased Lnc-ATB and reduced miR-200a/b/c levels, but the down-regulated miR-200c was most prominent. Up-regulated Lnc-ATB significant negatively correlated with miR-200c and predicted advanced TNM stage and more lymph node metastasis of CCA patients. Knockdown of Lnc-ATB in two CCA cell lines HuCCT1 and RBE increased miR-200c levels. The luciferase reporter assay further confirmed the direct binding site of miR-200c in Lnc-ATB. Inhibition of Lnc-ATB significantly impaired cell vitality and induced apoptosis and G0/G1 arrest, which, however, was rescued by miR-200c inhibitor. The ability of migration of CCA cells was also up-regulated by Lnc-ATB but was suppressed by miR-200c. Mechanistically, the cell cycle-related CCND1/CDK2, apoptosis-related BCL-2/caspase-3 and EMT-related E-cadherin/ZEB1/2 were regulated by Lnc-ATB via miR-200c. Knockdown of Lnc-ATB in vivo up-regulated miR-200c signals to inhibit tumor growth with decreased PCNA expression in tumor tissues, which was restored by miR-200c inhibition. |
Pubmed ID | 31571907 |
Year | 2019 |
Title | Up-regulated LncRNA-ATB Regulates the Growth and Metastasis of Cholangiocarcinoma via miR-200c Signals |
External Links
Links for lncRNA-ATB | GenBank HGNC NONCODE |
Links for cholangiocarcinoma | OMIM COSMIC |